ANGIO OCT 

The new non-invasive blood flow imaging technology (Angio-OCT) adopts a new technology, which displays vasculatures and retinal blood vessels in high-resolution layered without contrast agents. And capture data of fundus neovascularization or early fundus lesions caused by other diseases visually.

Blood flow map

high-resolution of images of retinal and vein membrane

OCTA2020 displays layered images of microvascular vessels at different depths fundus, which is helpful for doctors to accurately detect and analyze.

Fast, convenient and high-efficiency

OCTA2020 provides single-wire scanning centered on yellow spot, up to 11mm wide, imaging both yellow spots and the disc clearly at the same time.

Clinical Applications

• Can monitor the development of fundus disease anytime anywhere, assisting the personalized precision medical treatment of ophthalmological AMD and other diseases;

• Helps with early detection and stratified observation of diabetic retinopathy (DR).

• It is helpful to confirm diagnosis of retinal vein obstruction and vein retinopathy, showing abnormal branch blood vessels (BVN) of PCV (Polypoidal choroidal vasculopathy) noninvasive and so on. In addition, provide early diagnosis for RVO vascular abnormalities, optic nerve vascular abnormalities and other retinal diseases.

• It is helpful to understand the pathogenesis of glaucoma and neuro-ophthalmology diseases from the perspective of blood flow changes, and to clarify the structure and function changes of glaucoma and neuro-ophthalmology lesions.